Zelnorm (tegaserod) is now approved for idiopathic chronic constipation

October 2004

Zelnorm (tegaserod) is now approved for idiopathic chronic constipation.

This makes sense. Zelnorm stimulates GI motility.

It was initially approved for irritable bowel syndrome (IBS)...only in women who primarily had constipation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote